These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34845792)

  • 21. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
    Imaizumi M;
    Lung Cancer; 2005 Jul; 49(1):85-94. PubMed ID: 15949594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benefit of Uracil-Tegafur Used as a Postoperative Adjuvant Chemotherapy for Stage IIA Colon Cancer.
    Chen PH; Jhou HJ; Chung CH; Wu YY; Huang TC; Lee CH; Chien WC; Chen JH
    Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676634
    [No Abstract]   [Full Text] [Related]  

  • 23. The Effect of Tegafur-Uracil on Survival in T Categories as Defined in the Eighth Edition of the TNM Classification: An Exploratory Analysis of Postoperative Adjuvant Tegafur-Uracil on Survival in Patients with Adenocarcinoma of the Lung.
    Tsuboi M; Hamada C; Kato H; Ohta M
    Chemotherapy; 2017; 62(6):357-360. PubMed ID: 28817813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer.
    Hamada C; Tanaka F; Ohta M; Fujimura S; Kodama K; Imaizumi M; Wada H
    J Clin Oncol; 2005 Aug; 23(22):4999-5006. PubMed ID: 16051951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafur-uracil versus surgery alone in stage II colon cancer: SACURA trial.
    Matsuda C; Ishiguro M; Teramukai S; Kajiwara Y; Fujii S; Kinugasa Y; Nakamoto Y; Kotake M; Sakamoto Y; Kurachi K; Maeda A; Komori K; Tomita N; Shimada Y; Takahashi K; Kotake K; Watanabe M; Mochizuki H; Nakagawa Y; Sugihara K;
    Eur J Cancer; 2018 Jun; 96():54-63. PubMed ID: 29677641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uracil-tegafur in early-stage lung cancer.
    Altundag O; Altundag K; Gunduz M
    N Engl J Med; 2004 Aug; 351(7):713-4; author reply 713-4. PubMed ID: 15306675
    [No Abstract]   [Full Text] [Related]  

  • 27. Uracil-tegafur in early-stage lung cancer.
    Graziano F
    N Engl J Med; 2004 Aug; 351(7):713-4; author reply 713-4. PubMed ID: 15309743
    [No Abstract]   [Full Text] [Related]  

  • 28. Enhanced induction of apoptosis in lung adenocarcinoma after preoperative chemotherapy with tegafur and uracil (UFT).
    Morio A; Miyamoto H; Izumi H; Futagawa T; Oh T; Yamazaki A; Konno H
    Surg Today; 2004; 34(10):822-7. PubMed ID: 15449150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is adjuvant chemotherapy for completely resected p-stage IA (>2 cm) and stage IB non-small-cell lung cancer beneficial for elderly patients? A large, retrospective cohort study based on real-world data from Japan.
    Adachi H; Saito A; Shintani Y; Okami J; Ito H; Ohtsuka T; Mori T; Watanabe SI; Chida M; Endo S; Nakanishi R; Kadokura M; Suzuki H; Miyaoka E; Yoshino I; Date H; Japanese Joint Committee Of Lung Cancer Registry
    Jpn J Clin Oncol; 2023 Dec; 53(12):1191-1200. PubMed ID: 37626449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tegafur-uracil-induced pericardial effusion during adjuvant chemotherapy for resected lung adenocarcinoma: A case report.
    Kawamoto N; Okita R; Hayashi M; Okada M; Inokawa H
    Thorac Cancer; 2021 Mar; 12(5):707-710. PubMed ID: 33463035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metronomic chemotherapy with tegafur-uracil following radical resection in stage II colorectal cancer.
    Chen TC; Jeng YM; Liang JT
    J Formos Med Assoc; 2021 May; 120(5):1194-1201. PubMed ID: 33023787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxicity and Efficacy of Sequential Chemotherapy in Patients with p-stage I Non-small Cell Lung Cancer that Recurring during Postoperative Tegafur-Uracil Adjuvant Chemotherapy.
    Kashiwabara K; Semba H; Fujii S; Tsumura S
    Cancer Invest; 2018; 36(8):424-430. PubMed ID: 30234395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparable efficacy and safety of COVID-19 vaccines for patients receiving tegafur-uracil as postoperative adjuvant chemotherapy.
    Nishikubo M; Tanaka Y; Mitsui S; Doi T; Hokka D; Hojo W; Sakai H; Funakoshi Y; Yakushijin K; Ohji G; Minami H; Maniwa Y
    Surg Today; 2023 Sep; 53(9):1057-1063. PubMed ID: 36752867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC).
    Oki E; Murata A; Yoshida K; Maeda K; Ikejiri K; Munemoto Y; Sasaki K; Matsuda C; Kotake M; Suenaga T; Matsuda H; Emi Y; Kakeji Y; Baba H; Hamada C; Saji S; Maehara Y
    Ann Oncol; 2016 Jul; 27(7):1266-72. PubMed ID: 27056996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. UFT (tegafur and uracil) as postoperative adjuvant chemotherapy for solid tumors (carcinoma of the lung, stomach, colon/rectum, and breast): clinical evidence, mechanism of action, and future direction.
    Tanaka F
    Surg Today; 2007; 37(11):923-43. PubMed ID: 17952521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postoperative adjuvant chemotherapy with PVM (Cisplatin + Vindesine + Mitomycin C) and UFT (Uracil + Tegaful) in resected stage I-II NSCLC (non-small cell lung cancer): a randomized clinical trial. West Japan Study Group for lung cancer surgery (WJSG).
    Wada H; Miyahara R; Tanaka F; Hitomi S
    Eur J Cardiothorac Surg; 1999 Apr; 15(4):438-43. PubMed ID: 10371118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant chemotherapy for completely resected non-small-cell lung cancer.
    Suehisa H; Toyooka S
    Acta Med Okayama; 2009 Oct; 63(5):223-30. PubMed ID: 19893597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase III study of adjuvant gemcitabine compared with adjuvant uracil-tegafur in patients with completely resected pathological stage IB-IIIA non-small cell lung cancer (WJTOG0101).
    Yamaguchi M; Tada H; Mitsudomi T; Seto T; Yokoi K; Katakami N; Nakagawa K; Oda M; Ohta M; Sawa T; Yamashita M; Iked N; Saka H; Higashiyama M; Nomori H; Semba H; Negoro S; Chiba Y; Shimokawa M; Fukuoka M; Nakanishi Y;
    Int J Clin Oncol; 2021 Dec; 26(12):2216-2223. PubMed ID: 34463869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postoperative adjuvant chemotherapy for non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery. The Japan Lung Cancer Research Group on Postsurgical Adjuvant Chemotherapy.
    Wada H; Tanaka F; Hitomi S
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):98-102. PubMed ID: 9348578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic and predictive value of extended RAS mutation and mismatch repair status in stage III colorectal cancer.
    Sasaki Y; Akasu T; Saito N; Kojima H; Matsuda K; Nakamori S; Komori K; Amagai K; Yamaguchi T; Ohue M; Nagashima K; Yamada Y
    Cancer Sci; 2016 Jul; 107(7):1006-12. PubMed ID: 27089049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.